Inventor · disambiguated record
Pietro Genovese
Also filed as: GENOVESE PIETRO
9 granted patents·5 pending applications·247 citations·filing 2010–2024
86Inventor score
Files withOSPEDALE SAN RAFFAELE SRL5SANGAMO BIOSCIENCES INC3SANGAMO THERAPEUTICS INC3BONINI MARIA CHIARA1DANA FARBER CANCER INST INC1
Top patents by PatentIndex Score
14 records- 0195US8956828B2Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleasesBONINI MARIA CHIARA·Filed 2010·Granted Feb 17, 2015·203 cites·15 claims
- 0294US9937207B2Targeted disruption of T cell receptor genes using talensSANGAMO BIOSCIENCES INC·Filed 2014·Granted Apr 10, 2018·37 cites·13 claims
- 0384US10155011B2Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleasesSANGAMO BIOSCIENCES INC·Filed 2015·Granted Dec 18, 2018·4 cites·13 claims
- 0479US10918668B2Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleasesSANGAMO THERAPEUTICS INC·Filed 2018·Granted Feb 16, 2021·1 cites·9 claims
- 0578US10117899B2Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cellsSANGAMO BIOSCIENCES INC·Filed 2014·Granted Nov 6, 2018·2 cites·11 claims
- 0677US2023346844A1Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleasesSANGAMO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0776US12485187B2Method for improving retroviral transduction and gene editing in hematopoietic stem cells using clyclosporin H and UM171OSPEDALE SAN RAFFAELE SRL·Filed 2024·Granted Dec 2, 2025·0 cites·22 claims
- 0870US11439666B2Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleasesSANGAMO THERAPEUTICS INC·Filed 2018·Granted Sep 13, 2022·0 cites·12 claims
- 0962US2025170182A1Epitope engineering of cell-surface receptorsDANA FARBER CANCER INST INC·Filed 2023·Application pending·0 cites
- 1058US11964027B2Method for improving retroviral transduction and gene editing in hematopoietic stem cells using cyclosporine h (CsH)OSPEDALE SAN RAFFAELE SRL·Filed 2018·Granted Apr 23, 2024·0 cites·17 claims
- 1157US2023174622A1Epidermal growth factor receptorOSPEDALE SAN RAFFAELE SRL·Filed 2021·Application pending·0 cites
- 1248US2023365996A1Replacement of rag1 for use in therapyOSPEDALE SAN RAFFAELE SRL·Filed 2021·Application pending·0 cites
- 1345US12214055B2Systems and methods for treating hyper-igm syndromeEDITAS MEDICINE INC·Filed 2018·Granted Feb 4, 2025·0 cites·20 claims
- 1445US2022056484A1Selection by means of artificial transactivatorsOSPEDALE SAN RAFFAELE SRL·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pietro Genovese files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →